Premium
Letter: clinical response to pioglitazone in nonalcoholic steatohepatitis [ NASH ] treatment—use of pharmacokinetic surrogate
Author(s) -
Srinivas N. R.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14169
Subject(s) - nonalcoholic steatohepatitis , pioglitazone , medicine , surrogate endpoint , steatohepatitis , pharmacokinetics , nonalcoholic fatty liver disease , fatty liver , endocrinology , diabetes mellitus , disease , type 2 diabetes